对于失眠的认知行为治疗和不同类型的慢性失眠的lemborexant药物的疗效:随机对照试验的研究协议
Si-Jing Chen1,2,3, Hans Ivers1,2, Thien Thanh Dang-Vu4,5
1École de Psychologie, Université Laval, 2325 Rue Des Bibliothèques, Québec, Québec, G1V 0A6, Canada.
BMC psychiatry
|May 9, 2025
概括
这项研究比较了对失眠的认知行为疗法 (CBT-I) 和对不同失眠表型的lemborexant. 研究结果将为个性化的失眠治疗策略提供信息,以改善患者的治疗结果.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 临床心理学 临床心理学
背景情况:
- 失眠是一种普遍的疾病,患者的异质性显著影响治疗反应.
- 由于缺乏个性化的方法,当前的管理往往导致不理想的结果.
- 基于客观睡眠时间 (例如,<6小时) 的表型失眠对于定制干预至关重要.
研究的目的:
- 根据失眠表型,研究对失眠认知行为疗法 (CBT-I) 和lemorexant (药物治疗) 的治疗反应差异.
- 评估CBT-I和lemborexant在患有慢性失眠障碍和并发性焦虑/抑郁症状的成年人中的疗效.
- 探索治疗结果中的潜在调解者,如睡眠反应和唤醒.
主要方法:
- 一个三臂实用随机临床试验,招募了90名患有慢性失眠障碍的成年人.
- 参与者随机分配到CBT-I,lemorexant或安慰剂药物,在治疗后和6个月的随访期间进行评估.
- 主要结局:失眠严重程度指数;次要结局:睡眠/清醒变量,疲劳,情绪,幸福感,功能障碍,信仰和态度.
主要成果:
- 将分析失眠严重程度指数变化的主要结果数据,以比较治疗疗效.
- 二次结果将全面了解CBT-I和lemborexant对各种睡眠和心理参数的影响.
- 将对认知表现进行探索性分析,并通过睡眠反应和唤醒进行调解.
结论:
- 这项研究旨在通过确定不同患者表型的最佳治疗方法来推进针对失眠的个性化医疗.
- 这些发现将对睡眠研究和临床实践中的知识动员产生影响.
- 这项研究将有助于制定更有效和个性化的慢性失眠管理策略.
相关概念视频
01:19Management of Insomnia
220
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
220
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
129
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
129
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:27Insomnia
75
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
75
01:14CNS Depressants: Barbiturates and Benzodiazepines
180
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
180
01:15REM Sleep Behavior Disorder
113
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
113